In a double-blind, randomised, cross-over study, the pharmacokinetic/dynamic effects and subjective symptoms of a new controlled-release (CR) formulation of metoprolol (50 and 100 mg) have been compared with atenolol (50 mg) and placebo in 20 elderly healthy subjects. The metoprolol CR formulation d
Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone
β Scribed by E. Riva; P. L. Farina; R. Sega; G. Tognoni; W. Bastain; J. McAinsh
- Publisher
- Springer
- Year
- 1980
- Tongue
- English
- Weight
- 373 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The lipophilic betaβadrenoreceptor antagonist propranolol and hydrophilic atenolol have been studied to define their pharmacokinetic and pharmacodynamic characteristics in obese patients. A total of 43 subjects were allocated into three study groups: (1) healthy, lean, normolipaemic vol
The aim of the present study was to evaluate the central effects of single doses of the fi-adrenoceptor antagonist atenolol and the calcium antagonist nifedipine retard, alone and in combination, in normal subjects. Twelve normal males received single oral doses of atenolol 100 rag, nifedipine retar